Characterisation of liver fat in the UK Biobank cohort
Open accessThe DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease and the risk of progression to steatohepatitis, cirrhosis and hepatocellular carcinoma have been identified as major public health concerns. We have demonstrated the feasibility and potential value of measuring liver fat content by magnetic resonance imaging (MRI) in a large population in this study of 4,949 participants (aged 45-73 years) in the UK Biobank imaging enhancement. Despite requirements for only a single (≤3min) scan of each subject, liver fat was able to be measured as the MRI proton density fat fraction (PDFF) with an overall success rate of 96.4%. The overall hepatic fat distribution was centred between 1-2%, and was highly skewed towards higher fat content. The mean PDFF was 3.91%, and median 2.11%. Analysis of PDFF in conjunction with other data fields available from the UK Biobank Resource showed associations of increased liver fat with greater age, BMI, weight gain, high blood pressure and Type 2 diabetes. Subjects with BMI less than 25 kg/m2 had a low risk (5%) of high liver fat (PDFF > 5.5%), whereas in the higher BMI population (>30 kg/m2) the prevalence of high liver fat was approximately 1 in 3. These data suggest that population screening to identify people with high PDFF is possible and could be cost effective. MRI based PDFF is an effective method for this. Finally, although cross sectional, this study suggests the utility of the PDFF measurement within UK Biobank, particularly for applications to elucidating risk factors through associations with prospectively acquired data on clinical outcomes of liver diseases, including non-alcoholic fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This finding is consistent with a ‘floor effect’ for hepatic fat, which is unlikely to be reduced below the median of 2.1% observed in the large UK Biobank study27.”
From Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial (2024) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., Subbarayan, S., Webb, A., Hecht, J., & Cusi, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2739 · Cited by 200
RetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 2×
“A prospective study of 4949 subjects from the UK Biobank imaging enhancement protocol [27,28] acquired between August 2014 and October 2015.”
BackgroundMethodSelf-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“8% in different regions [4– 6], while prevalence in the USA has been estimated to be between 30% [7,8] and 46% [9].”
Background(2013) · Gastroenterology Research · doi:10.1053/j · Cited by 2,759
A Simple Generalisation of the Area Under the ROC Curve for Multiple Class Classification Problems
Hand, D. J., & Till, R. J. (2001) · Machine Learning · doi:10.1023/a:1010920819831 · Cited by 2,276 · cited 1×
“2 years [17] with 7% progressing to HCC in 6.”
BackgroundSimple proton spectroscopic imaging.
Dixon, W. T. (1984) · Radiology · doi:10.1148/radiology.153.1.6089263 · Cited by 2,276
Cited by
Items 101–157 of 157
Alonso, B. D. C., Shumbayawonda, E., Beyer, C., Hidalgo-Tobón, S., López-Martínez, B., Dies-Suárez, P., Klünder‐Klünder, M., Miranda‐Lora, A. L., Pérez, E. B., Thomaides-Brears, H. B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77307-8 · Cited by 7
Self-citationTonev, D., Shumbayawonda, E., Tetlow, L. A., Herdman, L., French, M., Rymell, S., Thomaides-Brears, H. B., Caseiro‐Alves, F., Castelo-Branco, M. S., Ferreira, C., et al. (2020) · JMIR Research Protocols · doi:10.2196/19189 · Cited by 8
Self-citationImage Processing and Quality Control for Abdominal Magnetic Resonance Imaging in the UK BiobankPreprint
Basty, N., Liu, Y., Cule, M., Thomas, E. L., Bell, J. D., & Whitcher, B. J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.01251 · Cited by 9
Self-citationMulti-organ imaging-derived polygenic indexes for brain and body healthPreprint
Yang, X., Sullivan, P. F., Li, B., Fan, Z., Ding, D., Shu, J., Guo, Y., Paschou, P., Bao, J., Shen, L., et al. (2023) · medRxiv · doi:10.1101/2023.04.18.23288769 · Cited by 10
Machine Learning Models for Screening Steatosis in MASLD : An International Validation Study
Ye, J., Feng, X., Lai, J., Zhuang, X., Li, X., Gong, X., Deng, H. X., Hu, Y., Dong, Z., Xu, L., et al. (2025) · Liver International · doi:10.1111/liv.70416 · Cited by 7
Freer, C. L., George, E. S., Tan, S., Abbott, G., Scott, D. S., & Daly, R. M. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01212-5 · Cited by 7
Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center
Alsuhaibani, K., Althunayyan, F. S., Alsudays, A. M., Alharbi, A. A., & Aljarallah, B. M. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_185_21 · Cited by 6
Yu, J., Zhou, Y., Yi, L., Zeng, R., Wan, Z., Li, D., Zhao, Q., & Liao, X. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15847 · Cited by 7
Chiyanika, C., Hui, S. C. N., Sin, D. M. C., Shumbayawonda, E., Wong, S. K. H., Ng, E. K., Yip, T. C., Wong, V. W., & Chu, C. W. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-148 · Cited by 6
Park, D., Shin, M., & Magkos, F. (2024) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2024.4.e13 · Cited by 5
Chiyanika, C., Shumbayawonda, E., Pansini, M., Liu, K. H., Yip, T. C., Wong, V. W., & Chu, C. W. (2024) · Clinical Obesity · doi:10.1111/cob.12712 · Cited by 6
Mantovani, A., Beatrice, G., Stupia, R., & Dalbeni, A. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.75 · Cited by 5
Jin, J., Li, B., Wang, X., Yang, X., Li, Y., Wang, R., Ye, C., Shu, J., Fan, Z., Xue, F., et al. (2025) · medRxiv · doi:10.1101/2025.02.07.25321875 · Cited by 6
UK Biobank: Transforming drug discovery and precision medicine
Bešević, J., Said, S., Nagy, R., Jamshidi, Y., Whelan, C. D., Carson, L., Rutter, M. K., Lewandowski, A. J., Effingham, M., Collins, R., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70254 · Cited by 4
Cuantificación de esteatosis hepática no alcohólica por resonancia magnética
Herrera, R., Peñaloza, F., Arrieta, C., Zacconi, F. C. M., Saavedra, V. M., Saavedra, C., Brañes, C., Hack, T., & Uribe, S. A. (2019) · Revista médica de Chile · doi:10.4067/s0034-98872019000700821 · Cited by 7
Zhou, C., Zhang, Y., Ye, Z., Zhang, Y., He, P., Liu, M., Yang, S., Gan, X., Xiang, H., Huang, Y., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.07.007 · Cited by 3
Liver‐Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac Dysfunction
Lian, L., Xia, T., Chen, Z., Wen, C. Y., Zhou, X., Xiao, T., Targher, G., Byrne, C. D., Yeo, Y. H., Ju, S., et al. (2026) · Liver International · doi:10.1111/liv.70548 · Cited by 4
New boundaries of liver imaging: from morphology to function
Cruz, M., Ferreira, A. A., Papanikolaou, N. K., Banerjee, R., & Caseiro‐Alves, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.06.004 · Cited by 4
Self-citationThe effects of resistance training on cardiovascular factors and anti-inflammation in diabetic rats
Yoo, J. C., Hwang, J., Choi, J., Ramalingam, M., Jeong, H., Jang, S., Jeong, H., & Kim, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37081 · Cited by 2
Fulda, E. S., Portas, L., Harper, C., Preiss, D., Bennett, D., & Doherty, A. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003738 · Cited by 2
Brown, E. E., Bilson, J., Alam, U., Goff, L. M., Kemp, G. J., Pfeiffer, A. F. H., Weickert, M. O., Umpleby, A. M., Byrne, C. D., & Cuthbertson, D. J. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112997 · Cited by 2
Liang, Z., Jin, H., Gao, W., Zhang, H., Hu, X., Li, R., Li, X., Cheng, Y., Guo, L., & Liu, Y. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00677 · Cited by 2
Jiang, R., Rosenblatt, M., Qi, S., Calhoun, V. D., Wang, Q., Wang, P., Wu, J. I. A. H. U. I., Scheinost, D., & Sui, J. (2026) · Science Advances · doi:10.1126/sciadv.aeg4939 · Cited by 2
Lian, L., Chen, Q., Xia, T., Huang, C., Wei, Y.-X., Targher, G., Byrne, C. D., Sperling, L. S., Lip, G. Y. H., Pang, Y., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156692 · Cited by 3
Feng, Q., Izzi‐Engbeaya, C. N., Manousou, P., & Woodward, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16562 · Cited by 2
Yang, L., Sun, Z., Li, J., Pan, X., Wen, J., Yang, J., Wang, Q., & Chen, P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.830445 · Cited by 2
Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver
Wilman, H., Jacobs, J., Newbould, R. D., Halberstadt, M., Gyngell, M., Herlihy, A., Fernandes, C., Kelly, C., Maguire, M., Jayaratne, N., et al. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)31381-3 · Cited by 2
Self-citationAlzoubi, O., Arar, A., Singh, V., Ertürk, Ş. M., Mózes, F. E., & Pavlides, M. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.6 · Cited by 3
Pillai, A., Bliznashki, K., Hutchison, E. R., Kumar, C., Challis, B., & Patel, M. N. (2022) · medRxiv · doi:10.1101/2022.03.25.22272965 · Cited by 3
Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition
Ahmad, S., Carrasquilla, G. D., Langner, T., Menzel, U., Ahmad, N., Sayols-Baixeras, S., Dekkers, K. F., Kennedy, B., Malmberg, F., Hammar, U., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101468 · Cited by 2
de Souza, J. G., Ittermann, T., Werner, N., Schipf, S., Friedrich, N., Nauck, M., Miname, M. H., Fernandes, F., Santos, R. D., Ghadri, J., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03289-8 · Cited by 1
Slice-to-Volume Registration Enables Automated Pancreas MRI Quantification in UK Biobank
Bagur, A. T., Aljabar, P., Arya, Z., McGonigle, J., Brady, M., & Bulte, D. P. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-80432-9_17 · Cited by 2
Ghodsian, N., Abner, E., Emdin, C. A., Gobeil, É., Taba, N., Haas, M. J., Perrot, N., Manikpurage, H. D., Gagnon, É., Bourgault, J., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-97977/v1 · Cited by 1
Deep regression for uncertainty-aware and interpretable analysis of large-scale body MRIPreprint
Langner, T., Strand, R., Ahlström, H. K., & Kullberg, J. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2105.07797 · Cited by 1
Wu, X., Zhou, R., Zhong, Q., Wu, X., Chen, H.-W., Wei, Y., Li, X., & Wu, X. (2025) · Research Square · doi:10.21203/rs.3.rs-6381296/v1 · Cited by 1
Die nichtalkoholische Fettlebererkrankung aus klinischer Sicht
Schumacher, F., & Koch, A. H. (2018) · Ernährung & Medizin · doi:10.1055/a-0638-6513
MR Based-Imaging Biomarkers in NAFLD/NASH
Pavlides, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-37173-9_8
Grecian, S. M. (2021) · ERA · doi:10.7488/era/1218 · Cited by 1
Atabaki‐Pasdar, N., Pomares‐Millan, H., Koivula, R. W., Tura, A., Brown, A. A., Viñuela, A., Agudelo, L. Z., Coral, D., van Oort, S., Allin, K. H., et al. (2021) · medRxiv · doi:10.1101/2021.08.31.21262709
Self-citationStanner, S., Coe, S., & Frayn, K. N. (2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Quantitative MR in Paediatric Patients with Wilson Disease: A Case Series Review
Janowski, K., Shumbayawonda, E., Kelly, M., Ferreira, C., Pronicki, M., Grajkowska, W., Naorniakowska, M., Pawliszak, P., Chełstowska, S., Jurkiewicz, E., et al. (2022) · Children · doi:10.3390/children9050613 · Cited by 4
Self-citationTavaglione, F., Jamialahmadi, O., Ljungman, C. E. A., & Romeo, S. (2023) · Liver International · doi:10.1111/liv.15598
Combined Weights LSTM-Based Deep Learning System for Predicting CVDS in NAFLD Patients
Sofia, A. J., & Bevi, A. R. (2023) · IEEE Global Conference for Advancement in Technology (GCAT) · doi:10.1109/gcat59970.2023.10353433
Lv, Y., Rong, S., Deng, Y., Bao, W., Xia, Y., & Chen, L. (2023) · Figshare · doi:10.6084/m9.figshare.24123774
Abbas, S. H., Ceresa, C. D. L., Hodson, L., Nasralla, D., Watson, C. J. E., Mergental, H., Coussios, C. C., Kaloyirou, F., Brusby, K., Mora, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734935
Abbas, S. H., Ceresa, C. D. L., Hodson, L., Nasralla, D., Watson, C. J. E., Mergental, H., Coussios, C. C., Kaloyirou, F., Brusby, K., Mora, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734938
Additional file 1 of Liver shape analysis using statistical parametric maps at population scale
Thanaj, M., Basty, N., Cule, M., Sorokin, E. P., Whitcher, B. J., Bell, J. D., & Thomas, E. L. (2024) · Figshare · doi:10.6084/m9.figshare.24971414
Self-citationTang, L., Li, D., Ma, Y., Cui, F., Wang, J., & Tian, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26637630
Scale it up: Large-scale MR data processing
Langner, T. (2025) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-14109-6.00017-1
Feng, Q., Manousou, P., Izzi‐Engbeaya, C. N., & Woodward, M. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03088-1
Feng, Q., Manousou, P., Izzi‐Engbeaya, C. N., Liu, J., & Woodward, M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70570
Bondonno, N. P., Pokharel, P., Parmenter, B. H., Zhong, L., Erichsen, D. W., Schullehner, J., Frederiksen, K., Kyrø, C., Hendriksen, P. F., Hodgson, J. M., et al. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106628
Circulating FGF21 levels reflect liver disease risk and metabolic stress in the UK Biobank
Yan, S., & Zhou, B. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.04.020
Chen, H., Wang, X., Chen, W., Xu, C., Tan, X. W., & Cao, Z. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03678-1 · Cited by 1
Mu, K., Zhang, J., Liang, S., Zhu, D., Zong, L., & Xue, J. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03343-5
Jakhar, N., Seibel, T., Mironova, M., Meeßen, C., Clusmann, J., Chen, Y., Raju, T. B., Koop, P., Pearce, J., Costa, I. G., et al. (2026) · Liver International · doi:10.1111/liv.70873
Xu, X., Stubbendorff, A., Borné, Y., Sonestedt, E., Huang, T., & Zhang, S. (2026) · The Innovation Nutrition · doi:10.59717/j.xinn-nutri.2026.100041
Metadata
- Authors
- Wilman, H. R., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A., Gyngell, M., Neubauer, S., Bell, J. D., Banerjee, R., & Thomas, E. L.
- Affiliations
- Perspectum Ltd. (United Kingdom) (GB)
- UK Biobank (GB)
- Imperial College London (GB)
- University of Oxford (GB)
- University of Westminster (GB)
- Corresponding author
- Thomas, E. Louise
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 2
- Pages
- e0172921
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5328634
- OpenAlex
- W2592225941
- Semantic Scholar
- dd6e2426ed5f28051c4cc16156363c47f4aa0135
- Cited by
- 159
- References
- 37
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 28 · 2023: 23 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 5 · 2018: 13 · 2017: 4
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-04-26)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WestminsterResearch (University of Westminster) (acceptedVersion)
- WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Innovate UK (GB) (010271)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- liver fat, non-alcoholic fatty liver disease, proton density fat fraction, magnetic resonance imaging, UK Biobank, body mass index, type 2 diabetes, blood pressure, weight gain, mass screening, risk factors
- MeSH terms
- Adipose Tissue, Age Factors, Aged, Cross-Sectional Studies, Female, United Kingdom, Humans, Image Processing, Computer-Assisted, Liver, Liver Diseases, Magnetic Resonance Imaging, Male, Middle Aged, Phenotype, Prospective Studies, Risk Factors, Body Mass Index, Treatment Outcome, Biological Specimen Banks, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.